DiaMedica Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $13,802 | $0 |
Gross Profit | -3 | -11 | 6,901 | -6,883 |
EBITDA | -7,690 | -8,133 | -8,408 | -6,873 |
EBIT | -7,693 | -8,144 | -8,419 | -6,883 |
Net Income | -7,699 | -7,707 | -7,900 | -6,274 |
Net Change In Cash | 0 | 0 | 13,802 | 0 |
Free Cash Flow | -7,604 | -7,161 | -6,441 | -4,479 |
Cash | 4,109 | 2,589 | 3,025 | 4,134 |
Basic Shares | 42,957 | 42,843 | 42,818 | 42,751 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -39 | -30 | -25 | -24 |
EBITDA | -24,375 | -19,308 | -13,976 | -13,622 |
EBIT | -24,414 | -19,338 | -14,001 | -13,646 |
Net Income | -24,444 | -19,381 | -13,676 | -13,592 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,101 | -18,752 | -11,592 | -12,274 |
Cash | 3,025 | 4,543 | 4,728 | 4,707 |
Basic Shares | 40,404 | 32,566 | 26,443 | 20,773 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.18 |
2025-03-31 | -$0.18 |
2024-12-31 | -$0.18 |
